Europe General Anesthesia Drugs Market Size & Outlook
Related Markets
Europe general anesthesia drugs market highlights
- The Europe general anesthesia drugs market generated a revenue of USD 1,515.4 million in 2024.
- The market is expected to grow at a CAGR of 3.2% from 2025 to 2030.
- In terms of segment, propofol was the largest revenue generating drug in 2024.
- Propofol is the most lucrative drug segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 1,515.4 million |
| Market revenue in 2030 | USD 1,827.8 million |
| Growth rate | 3.2% (CAGR from 2025 to 2030) |
| Largest segment | Propofol |
| Fastest growing segment | Propofol |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sevoflurane, Propofol, Dexmedetomidine, Remifentanil, Desflurane, Midazolam |
| Key market players worldwide | Baxter International Inc, AstraZeneca PLC, AbbVie Inc, B. Braun Medical, Fresenius SE & Co KGaA, Pfizer Inc, Hospira, Aspen Pharmacare Holdings Ltd, Hikma Pharmaceuticals PLC, Abbott Laboratories |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.6% of the global general anesthesia drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,759.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
General Anesthesia Drugs Market Scope
General Anesthesia Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Hospira | View profile | 10001+ | Lake Forest, Illinois, United States, North America | http://hospira.com |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| B. Braun Medical | View profile | 10001+ | Bethlehem, Pennsylvania, United States, North America | http://www.bbraunusa.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Aspen Pharmacare Holdings Ltd | View profile | 9161 | Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, Durban, NL, South Africa, | https://www.aspenpharma.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Europe general anesthesia drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to general anesthesia drugs market will help companies and investors design strategic landscapes.
Propofol was the largest segment with a revenue share of 26.46% in 2024. Horizon Databook has segmented the Europe general anesthesia drugs market based on sevoflurane, propofol, dexmedetomidine, remifentanil, desflurane, midazolam covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe general anesthesia drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe general anesthesia drugs market databook
-
Our clientele includes a mix of general anesthesia drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe general anesthesia drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Europe general anesthesia drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe general anesthesia drugs market size, by country, 2018-2030 (US$M)
Europe General Anesthesia Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
